Advanced search
Publication Cover
Journal of Neurogenetics Volume 29, 2015 - Issue 2-3
Submit an article Journal homepage
612
Views
9
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

What we have learned from the next-generation sequencing: Contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases

Yo-Tsen LiuDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan;Departement of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
,
Yi-Chung LeeDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan;Departement of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan;Brain Research Center, National Yang-Ming University, Taipei, Taiwan
&
Bing-Wen SoongDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan;Departement of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan;Brain Research Center, National Yang-Ming University, Taipei, TaiwanCorrespondence[email protected] [email protected]
Pages 103-112 | Received 03 Apr 2015, Accepted 08 Jun 2015, Published online: 09 Jul 2015

References

  • Albert, T. J., Molla, M. N., Muzny, D. M., Nazareth, L., Wheeler, D., Song, X., et al. (2007). Direct selection of human genomic loci by microarray hybridization. Nat Methods, 4, 903–905.
  • Antonellis, A., Ellsworth, R. E., Sambuughin, N., Puls, I., Abel, A., Lee-Lin, S. Q., et al. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet, 72, 1293–1299.
  • Antonicka, H., Ostergaard, E., Sasarman, F., Weraarpachai, W., Wibrand, F., Pedersen, A. M., et al. (2010). Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. Am J Hum Genet, 87, 115–122.
  • Barry, D. M., Millecamps, S., Julien, J. P., & Garcia, M. L. (2007). New movements in neurofilament transport, turnover and disease. Exp Cell Res, 313, 2110–2120.
  • Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., et al. (2011). Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med, 3, 65ra64.
  • Bettencourt, C., Ryten, M., Forabosco, P., Schorge, S., Hersheson, J., Hardy, J., et al. (2014). Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. JAMA Neurol, 71, 831–839.
  • Bouhouche, A., Benomar, A., Bouslam, N., Chkili, T., & Yahyaoui, M. (2006). Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet, 43, 441–443.
  • Caramins, M., Colebatch, J. G., Bainbridge, M. N., Scherer, S. S., Abrams, C. K., Hackett, E. L., et al. (2013). Exome sequencing identification of a GJB1 missense mutation in a kindred with X-linked spinocerebellar ataxia (SCA-X1). Hum Mol Genet, 22, 4329–4338.
  • Charlesworth, G., Plagnol, V., Holmstrom, K. M., Bras, J., Sheerin, U. M., Preza, E., et al. (2012). Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet, 91, 1041–1050.
  • Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A, 106, 19096–19101.
  • Chung, M. Y., Lu, Y. C., Cheng, N. C., & Soong, B. W. (2003). A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain, 126, 1293–1299.
  • Consugar, M. B., Navarro-Gomez, D., Place, E. M., Bujakowska, K. M., Sousa, M. E., Fonseca-Kelly, Z. D., et al. (2014). Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med, 17, 253–61. doi: 10.1038/gim.2014.1172.
  • Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., Chaib, H., et al. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA, 311, 1035–1045.
  • Doi, H., Yoshida, K., Yasuda, T., Fukuda, M., Fukuda, Y., Morita, H., et al. (2011). Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet, 89, 320–327.
  • Duarri, A., Jezierska, J., Fokkens, M., Meijer, M., Schelhaas, H. J., den Dunnen, W. F., et al. (2012). Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann Neurol, 72, 870–880.
  • Dufke, C., Schlipf, N., Schule, R., Bonin, M., Auer-Grumbach, M., Stevanin, G., et al. (2012). A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes. Neurogenetics, 13, 215–227.
  • Ebbing, B., Mann, K., Starosta, A., Jaud, J., Schols, L., Schule, R., et al. (2008). Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet, 17, 1245–1252.
  • Elsayed, S. M., Heller, R., Thoenes, M., Zaki, M. S., Swan, D., Elsobky, E., et al. (2014). Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations. Eur J Hum Genet, 22, 286–288.
  • Emmanuele, V., Lopez, L. C., Berardo, A., Naini, A., Tadesse, S., Wen, B., et al. (2012). Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol, 69, 978–983.
  • Foley, A. R., Menezes, M. P., Pandraud, A., Gonzalez, M. A., Al-Odaib, A., Abrams, A. J., et al. (2014). Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain, 137, 44–56.
  • Gnirke, A., Melnikov, A., Maguire, J., Rogov, P., LeProust, E. M., Brockman, W., et al. (2009). Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol, 27, 182–189.
  • Goh, G. & Choi, M. (2012). Application of whole exome sequencing to identify disease-causing variants in inherited human diseases. Genomics Inform, 10, 214–219.
  • Gonzalez, M., McLaughlin, H., Houlden, H., Guo, M., Yo-Tsen, L., Hadjivassilious, M., et al. (2013). Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry, 84, 1247–1249.
  • Gonzalez, M. A., Feely, S. M., Speziani, F., Strickland, A. V., Danzi, M., Bacon, C., et al. (2014). A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain, 137, 2897–2902.
  • Gunawardena, S. & Goldstein, L. S. (2004). Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. J Neurobiol, 58, 258–271.
  • Harms, M. B., Ori-McKenney, K. M., Scoto, M., Tuck, E. P., Bell, S., Ma, D., et al. (2012). Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology, 78, 1714–1720.
  • He, J., Mangelsdorf, M., Fan, D., Bartlett, P., & Brown, M. A. (2014). Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing. Neuroscientist, pii: 1073858414555404. [Epub ahead of print].
  • Hirokawa, N., Noda, Y., Tanaka, Y., & Niwa, S. (2009). Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol, 10, 682–696.
  • Hirschhorn, J. N. (2009). Genomewide association studies–illuminating biologic pathways. N Engl J Med, 360, 1699–1701.
  • Hodges, E., Rooks, M., Xuan, Z., Bhattacharjee, A., Benjamin Gordon, D., Brizuela, L., et al. (2009). Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing. Nat Protoc, 4, 960–974.
  • Hodges, E., Xuan, Z., Balija, V., Kramer, M., Molla, M. N., Smith, S. W., et al. (2007). Genome-wide in situ exon capture for selective resequencing. Nat Genet, 39, 1522–1527.
  • Jiang, T., Tan, M. S., Tan, L., & Yu, J. T. (2014). Application of next-generation sequencing technologies in Neurology. Ann Transl Med, 2, 125. doi: 10.3978/j.issn.2305–5839.2014.11.11.
  • Johnson, J. O., Gibbs, J. R., Megarbane, A., Urtizberea, J. A., Hernandez, D. G., Foley, A. R., et al. (2012). Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain, 135, 2875–2882.
  • Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., et al. (2010). Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron, 68, 857–864.
  • Jordanova, A., Irobi, J., Thomas, F. P., Van Dijck, P., Meerschaert, K., Dewil, M., et al. (2006). Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet, 38, 197–202.
  • Khan, T. N., Klar, J., Tariq, M., Anjum Baig, S., Malik, N. A., Yousaf, R., et al. (2014). Evidence for autosomal recessive inheritance in SPG3A caused by homozygosity for a novel ATL1 missense mutation. Eur J Hum Genet, 22, 1180–1184.
  • Kim, H. J., Kim, N. C., Wang, Y. D., Scarborough, E. A., Moore, J., Diaz, Z., et al. (2013). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature, 495, 467–473.
  • Klebe, S., Lossos, A., Azzedine, H., Mundwiller, E., Sheffer, R., Gaussen, M., et al. (2012). KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet, 20, 645–649.
  • Koppen, M., Metodiev, M. D., Casari, G., Rugarli, E. I., & Langer, T. (2007). Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol, 27, 758–767.
  • Kothiyal, P., Cox, S., Ebert, J., Husami, A., Kenna, M. A., Greinwald, J. H., et al. (2010). High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnol, 10, 10. doi: 10.1186/1472–6750-10–10.
  • Ku, C. S., Cooper, D. N., Polychronakos, C., Naidoo, N., Wu, M., & Soong, R. (2012). Exome sequencing: dual role as a discovery and diagnostic tool. Ann Neurol, 71, 5–14.
  • Latour, P., Thauvin-Robinet, C., Baudelet-Mery, C., Soichot, P., Cusin, V., Faivre, L., et al. (2010). A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet, 86, 77–82.
  • Lee, Y. C., Durr, A., Majczenko, K., Huang, Y. H., Liu, Y. C., Lien, C. C., et al. (2012). Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol, 72, 859–869.
  • Lee, Y. C., Lee, T. C., Lin, K. P., Lin, M. W., Chang, M. H., & Soong, B. W. (2010). Clinical characterization and genetic analysis of a possible novel type of dominant Charcot-Marie-Tooth disease. Neuromuscul Disord, 20, 534–539.
  • Liu, Y. T., Hersheson, J., Plagnol, V., Fawcett, K., Duberley, K. E., Preza, E., et al. (2014). Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation. J Neurol Neurosurg Psychiatry, 85, 493–498.
  • Liu, Y. T., Laura, M., Hersheson, J., Horga, A., Jaunmuktane, Z., Brandner, S., et al. (2014a). Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy. Neurology, 83, 612–619.
  • Lossos, A., Stumpfig, C., Stevanin, G., Gaussen, M., Zimmerman, B. E., Mundwiller, E., et al. (2015). Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia. Neurology, 84, 659–667.
  • MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., et al. (2014). Guidelines for investigating causality of sequence variants in human disease. Nature, 508, 469–476.
  • Marelli, C., Cazeneuve, C., Brice, A., Stevanin, G., & Durr, A. (2011). Autosomal dominant cerebellar ataxias. Rev Neurol (Paris), 167, 385–400.
  • Margolin, D. H., Kousi, M., Chan, Y. M., Lim, E. T., Schmahmann, J. D., Hadjivassiliou, M., et al. (2013). Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med, 368, 1992–2003.
  • Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272–276.
  • Oates, E. C., Rossor, A. M., Hafezparast, M., Gonzalez, M., Speziani, F., MacArthur, D. G., et al. (2013). Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet, 92, 965–973.
  • Okou, D. T., Steinberg, K. M., Middle, C., Cutler, D. J., Albert, T. J., & Zwick, M. E. (2007). Microarray-based genomic selection for high-throughput resequencing. Nat Methods, 4, 907–909.
  • Pandraud, A., Liu, Y.-T., & Houlden, H. (2012). Advances in the genetics of peripheral nerve disorders. Advances in clinical neuroscience and rehabilitation, 12, 8–13.
  • Pensato, V., Castellotti, B., Gellera, C., Pareyson, D., Ciano, C., Nanetti, L., et al. (2014). Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain, 137, 1907–1920.
  • Pierson, T. M., Adams, D., Bonn, F., Martinelli, P., Cherukuri, P. F., Teer, J. K., et al. (2011). Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet, 7, e1002325.
  • Pitceathly, R. D., Murphy, S. M., Cottenie, E., Chalasani, A., Sweeney, M. G., Woodward, C., et al. (2012). Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology, 79, 1145–1154.
  • Potgieter, M., Pretorius, E., & Pepper, M. S. (2013). Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev, 71, 180–188.
  • Riviere, J. B., Ramalingam, S., Lavastre, V., Shekarabi, M., Holbert, S., Lafontaine, J., et al. (2011). KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet, 89, 219–230.
  • Rossor, A. M., Polke, J. M., Houlden, H., & Reilly, M. M. (2013). Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol, 9, 562–571.
  • Schelhaas, H. J., Verbeek, D. S., Van de Warrenburg, B. P., & Sinke, R. J. (2004). SCA19 and SCA22: evidence for one locus with a worldwide distribution. Brain, 127, E6. author reply E7.
  • Schlipf, N. A., Schule, R., Klimpe, S., Karle, K. N., Synofzik, M., Schicks, J., et al. (2011). Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients. Clin Genet, 80, 148–160.
  • Shi, C. H., Schisler, J. C., Rubel, C. E., Tan, S., Song, B., McDonough, H., et al. (2014). Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet, 23, 1013–1024.
  • Shimazaki, H., Takiyama, Y., Ishiura, H., Sakai, C., Matsushima, Y., Hatakeyama, H., et al. (2012). A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet, 49, 777–784.
  • Singleton, A. B., Hardy, J., Traynor, B. J., & Houlden, H. (2010). Towards a complete resolution of the genetic architecture of disease. Trends Genet, 26, 438–442.
  • Soong, B. W., Huang, Y. H., Tsai, P. C., Huang, C. C., Pan, H. C., Lu, Y. C., et al. (2013). Exome sequencing identifies GNB4 mutations as a cause of dominant intermediate Charcot-Marie-Tooth disease. Am J Hum Genet, 92, 422–430.
  • Soong, B. W. & Paulson, H. L. (2007). Spinocerebellar ataxias: an update. Curr Opin Neurol, 20, 438–446.
  • Stum, M., McLaughlin, H. M., Kleinbrink, E. L., Miers, K. E., Ackerman, S. L., Seburn, K. L., et al. (2010). An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci, 46, 432–443.
  • Taft, R. J., Vanderver, A., Leventer, R. J., Damiani, S. A., Simons, C., Grimmond, S. M., et al. (2013). Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet, 92, 774–780.
  • Thompson, R., Drew, C. J., & Thomas, R. H. (2012). Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challenges. Adv Protein Chem Struct Biol, 89, 27–63.
  • Timmerman, V., Clowes, V. E., & Reid, E. (2013). Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp Neurol, 246, 14–25.
  • Tucci, A., Liu, Y. T., Preza, E., Pitceathly, R. D., Chalasani, A., Plagnol, V., et al. (2014). Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry, 85, 486–492.
  • Verbeek, D. S., Schelhaas, J. H., Ippel, E. F., Beemer, F. A., Pearson, P. L., & Sinke, R. J. (2002). Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet, 111, 388–393.
  • Vester, A., Velez-Ruiz, G., McLaughlin, H. M., Lupski, J. R., Talbot, K., Vance, J. M., et al. (2013). A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat, 34, 191–199.
  • Voelkerding, K. V., Dames, S. A., & Durtschi, J. D. (2009). Next-generation sequencing: from basic research to diagnostics. Clin Chem, 55, 641–658.
  • Wang, J. L., Yang, X., Xia, K., Hu, Z. M., Weng, L., Jin, X., et al. (2010). TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain, 133, 3510–3518.
  • Weedon, M. N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., et al. (2011). Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet, 89, 308–312.
  • Weihl, C. C., Baloh, R. H., Lee, Y., Chou, T. F., Pittman, S. K., Lopate, G., et al. (2015). Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord, 25, 289–96.
  • Willemsen, M. H., Vissers, L. E., Willemsen, M. A., van Bon, B. W., Kroes, T., de Ligt, J., et al. (2012). Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet, 49, 179–183.
  • Xia, C., Rahman, A., Yang, Z., & Goldstein, L. S. (1998). Chromosomal localization reveals three kinesin heavy chain genes in mouse. Genomics, 52, 209–213.
  • Xia, C. H., Roberts, E. A., Her, L. S., Liu, X., Williams, D. S., Cleveland, D. W., et al. (2003). Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol, 161, 55–66.
  • Xue, Y., Chen, Y., Ayub, Q., Huang, N., Ball, E. V., Mort, M., et al. (2012). Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet, 91, 1022–1032.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.